CV0501

mRNA vaccine encoding SARS-CoV-2 spike protein · GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CV0501, covering 2025-02-21 to 2025-02-21. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity Study of a Booster Dose of the Investigational CV0501 mRNA COVID-19 Vaccine in Adults at Least 18 Years Old [Phase 1]

See pricing